HB88 Alabama 2012 Session

Summary

Primary Sponsor

Mike Millican

Republican

Session

Regular Session 2012

Title

Ephedrine, pseudoephedrine, and phenylpropanolamine, State Board of Health required to classify as controlled substances, exemptions, wholesale drug distributors exempt from storage, record keeping and security control, Secs. 20-2-20, 20-2-181 am'd.

Summary

HB88 would classify ephedrine, pseudoephedrine, and phenylpropanolamine as Schedule III controlled substances in Alabama, require prescription sales for these ingredients, allow exemptions for certain meth-preventive formulations, and grant storage and reporting exemptions to some wholesale distributors.

What This Bill Does

The bill requires the State Board of Health to designate ephedrine, pseudoephedrine, and phenylpropanolamine as Schedule III controlled substances. It gives the board the authority to exempt products containing these substances from control if they are effectively formulated to prevent conversion to methamphetamine, and to revoke that exemption if the Department of Public Safety determines the exemption is not effective. It also exempts wholesale drug distributors licensed by the Board of Pharmacy and regulated by the U.S. Drug Enforcement Administration from storage, reporting, record-keeping, and physical security requirements related to these substances. The changes are made by amending Sections 20-2-20 and 20-2-181.

Who It Affects

• Consumers and patients who use products containing ephedrine, pseudoephedrine, or phenylpropanolamine would generally need a prescription to obtain these ingredients (unless an exempted product is available that is formulated to prevent meth production).
• Wholesale drug distributors licensed by the Alabama Board of Pharmacy and registered with the U.S. DEA would be exempt from certain storage, reporting, record-keeping, and security requirements for these substances.

Key Provisions

• Classify ephedrine, pseudoephedrine, and phenylpropanolamine as Schedule III controlled substances under Alabama law.
• authorize exemptions from classification for products containing these substances if they are effectively formulated to prevent conversion to methamphetamine, with the ability to revoke exemptions based on Department of Public Safety findings.
• exempt certain wholesale drug distributors from storage, reporting, record-keeping, and physical security control requirements related to these substances when they are classified as controlled substances under this bill.
• amend Sections 20-2-20 and 20-2-181 to implement these changes.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Controlled Substances